Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 5;12(5):1538–1547. doi: 10.7150/jca.52320

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The author(s)

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.

PMC Copyright notice

Association of plasma exosome-derived BTG-1 level with DFS in patients with NSCLC. (A) Among all patients with NSCLC, DFS was worse in patients who had low plasma exosome-derived BTG-1 levels compared with that in patients with high plasma exosome-derived BTG-1 levels (P < 0.001); (B) DFS was shorter in patients with low plasma exosome-derived BTG-1 levels than in patients with high plasma exosome-derived BTG-1 levels for those with TNM stage I (P = 0.019); (C) DFS was shorter in patients with low plasma exosome-derived BTG-1 levels than in patients with high plasma exosome-derived BTG-1 levels for those with TNM stage I II (P = 0.033); (D) DFS was shorter in patients with low plasma exosome-derived BTG-1 levels than in patients with high plasma exosome-derived BTG-1 levels for those with TNM stage III (P = 0.016).